It’s often said that there’s two sides to every story. And this is one of the reasons why I always get somewhat concerned when one side is silenced. Which, in turn, is why I took special note of a recent case involving Laidlaw & Company. They’re currently in a legal battle with a medical research company called Relmada Therapeutics. On the surface of things it’s easy to take the side of a company developing ways to treat sick people. But they also acquired a temporary restraining order and associated injunction against Laidlaw. And that made me a little concerned. I’ve never been a fan of any side of an argument not being able to equally express their side of things. The more I thought about it too, the more I remembered just how important investment firms can be to medical research. They’re also involved with helping people even if it’s in a somewhat less direct way.
I began to look into Laidlaw by going to their company website. The first thing that caught my attention was the human angle. The people at the very top are very clear about that fact. They’re not trying to stay faceless forces moving things around behind the scene. Instead, it’s quite clear that Matthew Eitner and James Ahern really believe in the company.
And the most striking thing about it is that they both seem very passionate about medical research. This further drives home the point that investment banks really are a major player in the medical industry. One has to imagine that Laidlaw and the people who work there probably have had a very big and positive influence on people’s lives.